{
   "keywords_list" : [
      "Alexion Pharmaceuticals",
      "Synageva BioPharma"
   ],
   "date" : "2015-05-6",
   "sources" : [
      {
         "name" : "New York Times",
         "permalink" : "https://www.nytimes.com/2015/05/07/business/dealbook/alexion-puts-its-soaring-stock-price-to-good-use.html",
         "month" : 5,
         "year" : "2015",
         "day" : "6",
         "hash" : "29bc0bac2efc26065458498ab893ba4ad2ad2641"
      }
   ],
   "images" : {},
   "index" : 1,
   "related" : [],
   "changes" : [],
   "slug" : "/feed/2015/05/6/alexion-pharmaceuticals-agrees-to-purchase-synageva-biopharma-a-maker-of-rare-disease-treatments-for-us-86-billion",
   "text" : "Alexion Pharmaceuticals agrees to purchase Synageva BioPharma, a maker of rare disease treatments, for US$8.6 billion. ",
   "keywords_main" : "Alexion Pharmaceuticals",
   "keywords" : [
      {
         "index" : 1,
         "name" : "Alexion Pharmaceuticals",
         "slug" : "/wiki/alexion%20pharmaceuticals"
      },
      {
         "slug" : "/wiki/synageva%20biopharma",
         "index" : 13,
         "name" : "Synageva BioPharma"
      }
   ],
   "hash" : "5e4f94ef64ba0c28bb4d83a84e39e2da8ad1297d"
}